Claris Life too gets UK regulator nod Ahmedabad-based drug maker Claris Lifesciences has received approval from the UK drug regulatory agency to sell milrinone injection and ketorolac trometamol solution for injection in the country. Milrinone ... Hindu Business Line, 4 days ago
Claris Lifesciences Q3 PAT up 32% at Rs 20 cr - Business Standard, 2 weeks ago
Claris Lifesciences (₹176.15): BUY - Hindu Business Line, 2 weeks ago
1 images for "claris lifesciences"
Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...PharmaBiz, 2 days ago
Shares of Glenmark Pharmaceuticals will likely remain in demand as the UK Medicines and Healthcare Regulatory Products Agency has allowed the company to sell cromviva capsules, used in the treatment of Gaucher's disease in the UK. Glenmark's arm ...Hindu Business Line, 4 days ago
The Organ Preservation Solutions Market to Reach USD 204.9 Million by 2019: Transparency Market Research
Transparency Market Research projects that the global market for organ preservation solutions will grow at a CAGR rate of 16.5% during the forecast period of 2013 to 2019 Albany, NY -- (ReleaseWire) -- 11/13/2014 -- In its latest research report ...Digital Journal, 1 week ago Global Organ Preservation Solutions Market 2014-2018 Stock Nod, 4 weeks ago Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org Red Orbit, 1 month ago
[November 07, 2014] (Indian Business Insight Via Acquire Media NewsEdge) Claris Lifesciences, sterile injectable manufacturer, has completed the transfer of its speciality injectable business to its subsidiary Claris Injectables.TMC Net, 2 weeks ago Claris Lifesciences : COMPLETES TRANSFER OF BIZ 4 Traders, 2 weeks ago Claris Life completes transfer of its speciality injectable biz to Claris Injectables Money Control, 3 weeks ago Claris completes transfer of speciality injectable business Business Standard, 3 weeks ago
|Hindu Business Line, 2 weeks ago Podcast (English): Claris Lifesciences by Lavanya Prabhakaran Hindu Business Line, 2 weeks ago|
This page uses frames, but your browser doesn'tCapital Market, 2 weeks ago Claris Lifesciences: Outcome of board meeting Money Control, 2 weeks ago
I am sure the company can give about 30% return in the next six months to 12 months. Hence, we suggest buying Claris Lifesciences. DON'T MISS any stories, follow us on Twitter Follow Follow this section for latest news on Recos EmailRSS Have something to say? ...Economic Times, 2 weeks ago
Capital Market November 11, 2014 Last Updated at 08:08 ISTBusiness Standard, 2 weeks ago Claris Lifesciences standalone net profit declines 42.08% in the September 2014 quarter HDFC Securities, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!